Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Balance Labs (BLNC) Liabilities and Shareholders Equity (2016 - 2025)

Balance Labs filings provide 12 years of Liabilities and Shareholders Equity readings, the most recent being $397506.0 for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 315.91% to $397506.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $614888.0, a 37.16% decrease, with the full-year FY2025 number at $397506.0, up 315.91% from a year prior.
  • Liabilities and Shareholders Equity hit $397506.0 in Q4 2025 for Balance Labs, up from $53140.0 in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $4.5 million in Q3 2021 to a low of $53140.0 in Q3 2025.
  • Median Liabilities and Shareholders Equity over the past 5 years was $397506.0 (2025), compared with a mean of $764793.6.
  • Biggest five-year swings in Liabilities and Shareholders Equity: soared 665.02% in 2021 and later crashed 87.57% in 2022.
  • Balance Labs' Liabilities and Shareholders Equity stood at $1.0 million in 2021, then tumbled by 57.7% to $429119.0 in 2022, then crashed by 48.56% to $220721.0 in 2023, then plummeted by 56.7% to $95575.0 in 2024, then soared by 315.91% to $397506.0 in 2025.
  • The last three reported values for Liabilities and Shareholders Equity were $397506.0 (Q4 2025), $53140.0 (Q3 2025), and $77232.0 (Q2 2025) per Business Quant data.